EGFR overexpression and activity could result in tumor growth and progression [26] and somatic mutations within the tyrosine kinase domain of EGFR, which have been identified in a subset of lung adenocarcinoma [27, 28]. Here, EGFR is linked to lung adenocarcinoma.